Exogenous surfactant as a drug delivery agent

被引:52
作者
Haitsma, JJ [1 ]
Lachmann, U [1 ]
Lachmann, B [1 ]
机构
[1] Erasmus Univ, Dept Anesthesiol, NL-3000 DR Rotterdam, Netherlands
关键词
antibiotics; pneumonia; ARDS; surfactant proteins; aminoglycosides; surfactant/agents interactions; lung injury;
D O I
10.1016/S0169-409X(01)00106-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pulmonary surfactant is a complex mixture of lipids and several specific surfactant proteins, which together render it with unique spreading properties and a dynamic surface tension behavior. These characteristics are heralded as ideal for a carrier of choice to instil therapeutic agents into the lung, because this combination enables high local therapeutic levels while minimizing systemic side-effects of the instilled agent. This review outlines the rationale to use exogenous surfactant in lung injury, including opening-up inaccessible regions of the lung to other therapeutic agents. Especially the combination of anti-microbial agents and surfactant offers an alternative for critically ill patients with pneumonia. Some caution is also indicated in combining surfactant with antibiotics without proper evaluation of possible interactions. Some other applications for surfactant as a carrier are discussed. Overall, the benefits of surfactant as a carrier warrants clinical trials and promises additional therapeutic tools for the clinician. (C) 2001 Elsevier Science B.V, All rights reserved.
引用
收藏
页码:197 / 207
页数:11
相关论文
共 47 条
[1]  
[Anonymous], Z GES EXP MED
[2]   REPORT OF THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ACUTE RESPIRATORY-DISTRESS SYNDROME - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
Cochin, B ;
Lanken, PN ;
Leeper, KV ;
Marini, J ;
Murray, JF ;
Oppenheimer, L ;
Pesenti, A ;
Reid, L ;
Rinaldo, J ;
Villar, J ;
van Asbeck, BS ;
Dhainaut, JF ;
Mancebo, J ;
Matthay, M ;
Meyrick, B ;
Payen, D ;
Perret, C ;
Fowler, AA ;
Schaller, MD ;
Hudson, LD ;
Hyers, T ;
Knaus, W ;
Matthay, R ;
Pinsky, M ;
Bone, RC ;
Bosken, C ;
Johanson, WG ;
Lewandowski, K ;
Repine, J ;
Rodriguez-Roisin, R ;
Roussos, C ;
Antonelli, MA ;
Beloucif, S ;
Bihari, D ;
Burchardi, H ;
LeMaire, F ;
Montravers, P ;
Petty, TL ;
Robotham, J ;
Zapol, W .
JOURNAL OF CRITICAL CARE, 1994, 9 (01) :72-81
[3]   CHANGES IN PULMONARY SURFACTANT DURING BACTERIAL PNEUMONIA [J].
BROGDEN, KA .
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, 1991, 59 (04) :215-223
[4]  
CLEMENTS JA, 1957, P SOC EXP BIOL MED, V95, P170
[5]   SUBLETHAL HYDROGEN-PEROXIDE INHIBITS ALVEOLAR TYPE-II CELL SURFACTANT PHOSPHOLIPID BIOSYNTHETIC-ENZYMES [J].
CRIM, C ;
LONGMORE, WJ .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (01) :L129-L135
[6]   EFFECT OF SURFACTANT REPLACEMENT ON PNEUMOCYSTIS-CARINII PNEUMONIA IN RATS [J].
EIJKING, EP ;
VANDAAL, GJ ;
TENBRINCK, R ;
LUIJENDIJK, A ;
SLUITERS, JF ;
HANNAPPEL, E ;
LACHMANN, B .
INTENSIVE CARE MEDICINE, 1991, 17 (08) :475-478
[7]   PULMONARY SURFACTANT MAINTAINS PATENCY OF CONDUCTING AIRWAYS IN THE RAT [J].
ENHORNING, G ;
DUFFY, LC ;
WELLIVER, RC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (02) :554-556
[8]   Surfactant versus saline as a vehicle for corticosteroid delivery to the lungs of ventilated rabbits [J].
Fajardo, C ;
Levin, D ;
Garcia, M ;
Abrams, D ;
Adamson, I .
PEDIATRIC RESEARCH, 1998, 43 (04) :542-547
[9]   Is outcome from ARDS related to the severity of respiratory failure? [J].
Ferring, M ;
Vincent, JL .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (06) :1297-1300
[10]   PRENATAL DEVELOPMENT OF LUNG ANTIOXIDANT ENZYMES IN 4 SPECIES [J].
FRANK, L ;
SOSENKO, IRS .
JOURNAL OF PEDIATRICS, 1987, 110 (01) :106-110